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Abstract
The tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC) is dynamic, with an extensive interaction
between the stroma and tumor cells. The aim of this study was to delineate the cross talk between PDAC and
cancer-associated fibroblasts (CAFs), with a focus on the mechanism creating the chronic inflammatory tumor mi-
lieu. We assessed the effects of the cross talk between PDAC and CAF cell lines on the creation and sustenance of
the inflammatory tumor microenvironment in pancreatic cancer. The coculture of PDAC and CAF cell lines enhanced
the levels of inflammatory factors including IL-1α, IL-6, CXCL8, VEGF-A, CCL20, and COX-2. CAFs were superior to
tumor cells regarding the production of most inflammatory factors, and tumor cell–associated IL-1α was established
as the initiator of the enhanced production of inflammatory factors through the binding of IL-1α to IL-1 receptor 1
(IL-1R1) expressed predominantly by CAFs. Furthermore, we found a correlation between IL-1α and CXCL8
expression levels in PDAC tissues and correlation between IL-1α expression and the clinical outcome of the
patients. This confirmed an important role for the IL-1 signaling cascade in the creation and sustenance of a tumor
favorable microenvironment. Neutralization of the IL-1α signaling efficiently diminished the cross talk–induced
production of inflammatory factors. These data suggest that the cross talk between PDAC cells and the main
stroma cell type, i.e. CAFs, is one essential factor in the formation of the inflammatory tumor environment,
and we propose that neutralization of the IL-1α signaling might be a potential therapy for this cancer.
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Introduction
Survival rates for the most prevalent cancers, such as breast and colon
cancers, have improved during the last two decades, whereas only mi-
nor advances have been reported regarding pancreatic ductal adeno-
carcinoma (PDAC) [1]. Adenocarcinomas, in particular PDAC, have
a vast stromal reaction, that is, desmoplasia, which infiltrates and en-
wraps the cancer cells [2,3] and may account for 70% of the total tumor
mass [4]. New evidence points to an interlinked relationship between
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PDAC and its stroma, which promotes tumor growth andmetastasis by
supporting vascularization, recruitment of inflammatory cells, and acti-
vation of fibroblasts [5]. The transformation of fibroblasts in PDAC
into cancer-associated fibroblasts (CAFs) is linked with several genetic
andmorphologic changes and seems to be driven by the tumor cells [6].
The mechanisms underlying the assembly and maintenance of the
tumor stroma are complex and not fully understood. In PDAC, the
tumor cells are believed to produce cytokines, such as interleukins (IL)
1 and 6, CXCL8, and tumor necrosis factor α, and growth factors, such
as PDGF and transforming growth factor β with the potential to activate
CAFs [7]. When activated, CAFs produce high levels of growth factors,
and inflammatory molecules that maintain their activated phenotype and
influence the surrounding cells [8]. The inflammatory environment cre-
ated by the CAFs supports tumor growth and progression and the re-
cruitment of leukocytes such as macrophages, dendritic cells, T cells,
and neutrophils [9].
In PDAC, several inflammatory factors, such as COX-2 and
CXCL8, have been investigated to determine their role in tumor devel-
opment, angiogenesis, and correlation to disease severity [10,11]. Pro-
duction of many of these factors by tumor cells, stroma, and immune
cells is initiated by proinflammatory factors, such as IL-1 and tumor
necrosis factor α. IL-1 is proposed to be involved in the earliest stages
of carcinogenesis by stimulating phagocytes and fibroblasts to produce
mutagenic reactive oxygen intermediates and to stimulate proliferation
of the premalignant cells [12]. The exact pathways involved in this in-
flammatory cascade in the tumor are not known. The levels of IL-1α
expression have been shown to associate with a virulent tumor pheno-
type and liver metastases for gastric cancers, for example [13].
Recently, the research focus has shifted from studying mainly the tu-
mor cells to investigating the tumor microenvironment as an entity con-
sisting of several components that are tightly interlinked. Few studies
exist where the interactions between cancer cells and stroma components,
such as CAFs, have been investigated and include breast, prostate, and
pancreatic carcinomas [14–17]. We hypothesized that the cross talk be-
tween PDAC cells and stroma, that is, CAFs, may be the initiator and
sustainer of cancer-associated inflammation. The aims of this study were
to characterize the inflammatory factors involved in and upregulated by
the cross talk between tumor cells and CAFs and to delineate the path-
way responsible for creating the inflammatory environment.
Our findings show that the inflammatory environment observed
in PDAC is dependent on the interaction between cancer cells and
CAFs. The inflammatory profiles detected in vivo in tumor tissues
were comparable to the findings from the in vitro cross talk model
with a high expression of inflammatory factors in the fibrotic stroma,
namely, CAFs. Our data implicate a vital role for the IL-1α signaling
pathway in the sustainment of the inflammatory microenvironment
in the tumor and for the patient’s survival time. This observation sug-
gests that treatment of the chronic inflammation in individuals with
PDAC by neutralizing IL-1 may be beneficial because it is expected to
drastically decrease the amount of angiogenic and metastatic asso-
ciated factors and may possibly even restore the immune system’s abil-
ity to fight the cancer.
Materials and Methods
PDAC Patients
Tumor tissues from a total of 30 patients with PDAC and 10 normal
pancreatic tissues from individuals who died of hypothermia or from
patients with benign pancreatic diseases were used in this study. PDAC
tissues were collected from patients undergoing pancreatic Whipple re-
sections at Linköping University Hospital. PDAC was histologically
confirmed by two pathologists, independently investigating the sam-
ples. The PDACs were staged according to the 1997 International
Union Against Cancer classification (TNM = tumor, node, metastasis)
and they ranged from T1 to T4 (T1 [n = 3], T2 [n = 14], T3 [n = 12],
and T4 [n = 1]), N0 (n = 6), N1 (n = 24), and M0 (n = 30) stage.
Consent documents and study protocols for both patient and control
samples were approved by the regional ethics committee in Linköping,
Sweden (Dnr. M38-06).
Propagation of PDAC Cell Lines and CAFs
Primary PDAC or CAF cell lines were propagated from PDAC tu-
mor tissue biopsies obtained from patients PC013, PC039, PC055,
PC065, PC073, and PC077. Tumor samples were cut into small pieces
and incubated in Hank’s balanced salt solution buffer (Invitrogen,
Stockholm, Sweden) supplemented with 0.3 M CaCl2 and 1 mg/ml
Collagenase II (Invitrogen) under gentle agitation at 37°C for 1 hour.
The samples were centrifuged, and the cell pellet was resuspended in
RPMI 1640 (Fisher Scientific, Pittsburgh, PA); supplemented with 20%
fetal calf serum (Invitrogen), 2 mM HEPES (Invitrogen), 30 μg/ml
gentamicin (Invitrogen), and 1% Fungizone (Invitrogen); and cul-
tured in tissue flasks. The cells were detached using trypsin-EDTA
(Invitrogen) when they reached confluence and labeled with CD326
microbeads, and tumor cells were positively selected according to
the manufacturer’s description (Miltenyi Biotec, Bergisch Gladbach,
Germany). The primary PDAC cell lines were cultured for five passages,
harvested, and cryopreserved. CD326-negative cells, that is, CAFs, were
cultured for two passages, harvested, and cryopreserved until later use.
The PDAC cell lines used were our primary cell lines PC013, PC065,
and PC077, and the commercial PDAC cell line BXPC-3 was pur-
chased from ATCC (LGC Standards, Stockholm, Sweden). Three
PDAC-derived CAF cell lines, CAF039, CAF055, and CAF073, were
used in the experiments performed in the present study.
In Vitro Coculture of PDAC Cells and Fibroblasts
PDAC and CAF cell lines were cultured together or alone for
5 days in RPMI 1640 supplemented with 10% fetal calf serum,
2 mM HEPES, and 30 μg/ml gentamicin (R10). The amount of
CAFs in the cocultures was kept constant, whereas the amount of
tumor cells differed between the PDAC cell lines to best mimic
the natural environment of the tumor, that is, CAFs constituted most
of the culturing area (60%-70%) after 5 days of culturing. After co-
culture, the PDAC cells were separated from the CAFs by staining with
Allophycocyanin (APC)-conjugated anti-CD326 antibodies (Miltenyi
Biotec) followed by sorting on a FACSAria Cell Sorter (BD Bio-
sciences, San Jose, CA). PDAC cells and CAFs were also indirectly co-
cultured in R10 medium for 5 days using Transwell culturing inserts
(BD Biosciences) to examine the importance of cell contact. Singly cul-
tured CAFs were incubated for 5 days in R10 medium supplemented
with 10 pg/ml human recombinant IL-1α (200-LA-002; R&D Sys-
tems, Abingdon, United Kingdom) to investigate the involvement of
IL-1α in the up-regulation of inflammatory factors in CAFs. The cells
were then lysed in RLT Buffer (Qiagen, Sollentuna, Sweden) contain-
ing 1% β-mercaptoethanol (Sigma Aldrich, Inc, St Louis, MO) and
stored at −70°C until preparation of RNA.
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Neutralization of IL-1
For complete inhibition of IL-1 activity, PDAC cells and CAFs
were cultured as single and cocultures for 5 days in R10 containing
10 μg/ml recombinant IL-1RA (Kineret 100 mg; Biovitrum AB,
Stockholm, Sweden). To distinguish between the two IL-1 agonists,
the IL-1 activity was blocked by incubating cocultured PC013 and
CAF039 cells for 5 days with 25 μg/ml IL-1α– (MAB200; R&D Sys-
tems) or IL-1β– (AB-201-NA; R&D Systems) neutralizing antibodies.
The cell cultures were then treated as described previously.
Gene Array Analysis of Single and Cocultured PDAC Cell Line
and CAF
The PC013 and CAF039 cell lines were cocultured or cultured sep-
arately for 5 days in R10 culture medium. After culture, the cells were
harvested, sorted into pure population of PDACs and CAFs, and RNA
was extracted using the RNeasy Mini Kit according to the manufac-
turer’s description (Qiagen). The quality of the total RNA was assessed
using Agilent RNA 6000 Nano kit (Agilent Technologies, Böblingen,
Germany), and the RNA was used to make first-strand complementary
DNA (cDNA) followed by second-strand cDNA synthesis according to
the manufacturer’s protocol (Affymetrix, Woodburn Green, United
Kingdom). The double-stranded cDNA was purified using the Sample
Cleanup Module and cDNA Cleanup Spin Columns (Affymetrix) and
biotin-labeled antisense complementary RNA was synthesized using
GeneChip IVT labeling kit (Affymetrix). The biotin labeled comple-
mentary RNA was purified, fragmented, hybridized to the gene chips
(GeneChip HG U133 Plus 2.0; Affymetrix), stained with streptavidin-
phycoerythrin in an Affymetrix Fluidics Station 450 using the Affymetrix
GeneChip protocol, and scanned using the Affymetrix GeneChip Scan-
ner 3000. The acquisition and initial quantification of array images
were done using the GCOS software (Affymetrix). Subsequent data
analysis involved the normalization of array values using PMA soft-
ware followed by nonsupervised hierarchical clustering using d-Chip
software (www.dchip.org; gene array accession no. E-MEXP-2826).
Quantification with Real-time Polymerase Chain Reaction
Total RNA was prepared from the samples using RNA Easy Mini
kit (Qiagen), and cDNA was synthesized with SuperScript III Re-
verse Transcriptase First-Strand cDNA Synthesis kit according to the
manufacturer’s protocol (Invitrogen). Quantitative polymerase chain
reaction (PCR) was performed with Fast SYBR Green Master Mix
(Version 09/2007; Applied Biosystems, Foster City, CA) on 7900 Fast
Real-time PCR System with 7900 System SDS 2.3 Software (Applied
Biosystems) according to the manufacturer’s protocol. The final con-
centration of the primers was 100 nM. In the negative controls, cDNA
was replaced by distilled water. The final amount of cDNA in each
reaction was comparable to 1 ng of RNA. The PCR program was set
for 40 cycles at 95°C for 20 seconds, 95°C for 1 second, and 60°C
for 20 seconds. At the end of the reaction, a dissociation curve anal-
ysis was performed. Specific primers for CXCL8, CCL20, IL-1α,
IL-1β, IL-6, IL-11, IL-24, IL-32, IL-1R1, IL-1RA, vascular endothe-
lial growth factor (VEGF-A; CyberGene AB, Stockholm, Sweden),
and COX-2 (Invitrogen) were used. β -Actin and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; CyberGene AB) were used as
housekeeping genes. The primers were designed using Primer Express
(Applied Biosystems) if not otherwise indicated. Real-time PCRs for
the detection of CXCL chemokines were performed using TaqMan
Gene Expression Assays (Applied BioSystems) according to the manufac-
turer’s protocol. All reactions were performed in triplicates includ-
ing none-template controls and two endogenous control probes.
FAM-conjugated gene-specific assays were Hs00236937_m1 (CXCL1),
Hs00236966_m1 (CXCL2 ) Hs00171061_m1 (CXCL3 ) ,
Hs00171085_m1 (CXCL5), Hs00237017_m1 (CXCL6 ), and the en-
dogenous controls Hs01003267_m1 (HPRT1) and Hs99999905_m1
(GAPDH ). The results were analyzed using the ΔΔC t method [18] and
presented as either normalized data or as relative gene expression.
Enzyme-Linked Immunosorbent Assay and Cytokine Array
Supernatants from single or cocultured PDAC and CAF cell lines
were harvested and cryopreserved until assessment for inflammatory
factors. The concentrations of IL-1α, IL-1β (Nordic Biosite, Täby,
Sweden), IL-1RA (R&D Systems), IL-6, and CXCL8 (eBioscience,
San Diego, CA) were evaluated by enzyme-linked immunosorbent
assay according to the manufacturers’ protocols. IL-1β was analyzed
in supernatants after 5 days of culturing and in plasma from 25 PDAC
patients by Bio-Plex Human cytokine 27-plex panel (Biorad Labora-
tories, Inc, Hercules, CA) as explained elsewhere [19].
Immunohistochemical Analysis of PDAC Tissue Samples
Formalin-fixed paraffin-embedded samples of tumor tissue from
PDAC patients (n = 7) and normal pancreas tissues obtained from
individuals (n = 7) who had died of hypothermia were used. The sam-
ples were pretreated with H2O2, followed by 1% albumin solution,
and immunostained using mouse anti–human monoclonal antibodies
(mAbs), Ki-67 (DakoCytomation, Glostrup, Denmark), and CXCL8
(BD Biosciences), and rabbit anti–human IL-1α (ab7632), IL-1RA
(ab2573), and IL-1R1 (ab59995), all from Abcam (Cambridge, United
Kingdom) and incubated overnight at room temperature. Samples
were then incubated with alkaline phosphatase–conjugated and/or
biotin-conjugated anti–mouse or anti–rabbit secondary Abs ( Jackson
ImmunoResearch, Suffolk, United Kingdom). Samples stained with
biotin conjugated secondary Abs were further incubated with avidin-
biotin complex (DakoCytomation) according to the manufacturer’s
protocol. Peroxidase was detected by development in Tris buffer con-
taining diaminobenzidine tetrahydrochloride (Saveen-Werner AB,
Limhamn, Sweden) and 10 μl of 30% H2O2. Alkaline phosphatase
was detected by Vulcan fast red chromogen 2 solution (Biocare Med-
ical, Concord, CA) according to the manufacture’s protocol. All tis-
sue sections were counterstained with methyl green solution (0.1 M
sodium acetate buffer, pH 4.2) containing 1% methyl green (Sigma
Aldrich). Images representative of patients were processed using
Quantimet 500 MC image processing analysis systems linked to a
Leica DM LBmicroscope (Leica Cambridge, United Kingdom) sup-
ported by Leica QWin software version 3 (Leica).
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 5 (GraphPad
Software, La Jolla, CA). P < .05 was considered statistically significant,
and error bars throughout indicate SEM. Nonparametric data were
analyzed using the Wilcoxon matched-pairs test followed by Mann-
Whitney test, and paired t test was used for normalized data. Correla-
tion was determined using Spearman nonparametric correlation. The
Kaplan-Meier estimator was used to compare different patient groups,
and P values were calculated using the log-rank (Mantel-Cox) test.
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Results
Cross Talk between PDAC and CAF Creates an
Inflammatory Microenvironment
The PDAC-CAF coculture system used for primary PDAC and
CAF cell lines created a pattern similar to the one seen in PDAC tumor
tissues with the formation of “tumor nests” surrounded by stroma, that
is, fibroblasts (Figure W1A). Characterization of the primary CAF cell
lines propagated from PDAC tissues, demonstrating that these cells
expressed markers well established for myofibroblasts/CAFs, alpha
smooth muscle actin (α-SMA), and vimentin (Figure W1B) [20,21].
Tumor cells were positive and CAFs negative for the epithelial cell
marker, EpCAM (CD326) (Figure W1, C and D), and this marker
was used to obtain pure populations of tumor cells and CAFs from
the cocultures by cell sorting (FACS) (Figure W1E). We first sought
to assess the gene profile induced by the cross talk between PDAC cells
and CAFs. Gene arrays (n = 2) were performed on primary PDAC cell
line PC013 and CAF cell line CAF039 after 5 days of culture, either
Figure 1. Inflammatory profile induced by cross talk between PDAC and CAF cell lines. Gene expression levels from one representative
gene array experiment of two assessed in single (S) and cocultured (CC) PC013 and CAF39 for several inflammatory factors (A). PDAC
cell lines PC013, BXPC-3, PC065, and PC077 and CAF cell lines CAF039, CAF055, and CAF073 were cultured alone (S) (B) or cocultured
(CC) (C) for 5 days and assessed for expression levels of inflammatory factors (IL-1α, IL-1β, IL-1R1, IL-6, IL-24, IL-32, CCL20, VEGF-A,
COX-2, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL8) by quantitative RT-PCR. (B) The gene levels in CAFs were compared against
the levels in PDAC cell lines as percent difference. (C) All data were pooled together, and the levels in (S) CAFs were compared against
the levels in (CC) CAFs as percent difference (n = 10). Data were analyzed using paired t test: *P < .05, **P < .005, and ***P < .001.
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single or cultured together (cocultured cells were sorted into pure
PDAC cells and CAFs; Figure W1E). The gene array profiles proved
up-regulation of several inflammatory genes in CAF039 after cross talk
with tumor cells, for example, IL-1α, IL-1β, CXCL1, CXCL8, IL-6,
and CCL20 (Figures 1A and W1F ). Furthermore, COX-2, an enzyme
that produces prostaglandins and is upregulated at sites of inflamma-
tion, was elevated both in CAF039 and in PC013 due to their cross
talk (Figures 1A and W1F ). The inflammatory signatures generated
by the cross talk initiated by the PC013 and CAF039 cell line were
confirmed using four different PDAC cell lines, namely, three primary
(PC013, PC065, and PC077) propagated from our tumor tissues and
one commercial (BXPC-3), as well as three primary CAF cell lines
(CAF039, CAF055, and CAF073). Levels of inflammatory factors
expressed by singly cultured CAFs were compared with PDAC cell lines
(Figure 1B). CAFs were the superior producers of most inflammatory
factors, e.g., CXCL1 (P = .025), CXCL6 (P = .013), CXCL8 (P =
.015), IL-24 (P = .028), IL-1R1 (P = .026), and IL-6 (P = .042),
whereas PDAC cells expressed high levels of proinflammatory factors
IL-1α (P < .001), IL-32 (P = .0049), and CCL20 (P < .001)
(Figure 1B). After the PDAC-CAF cross talk, CAFs had significantly
increased expression levels of inflammatory factors, namely, IL-1α
(P = .004), IL-1β (P = .035), IL-6 (P = .031), CCL20 (P = .043),
VEGF-A (P = .023), and CXCL5 (P = .001), whereas the expression
of IL-1R1 (P < .001) was significantly decreased (Figure 1C ). Note-
worthy, our findings indicate that the PDAC cells act as the instigator
of the inflammatory factors, known to affect different aspects of tu-
mor progression, survival, and metastasis, expressed by the CAFs (Fig-
ure 1C ). Furthermore, Gene Set Enrichment Analysis (GSEA) and
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway maps
derived from our gene array data indicated an important role for the
IL-1 family as the initiator/sustainer of the inflammation.
Expression of IL-1 and IL-RA by PDAC and Their Receptor
IL-1R1 by CAF Cell Lines
IL-1 is a known regulator and determinator of immune and in-
flammatory responses, and in light of our findings from the cross talk
gene array and quantitative PCR, we investigated in detail the IL-1
family expression profile in PDAC and CAF cell lines. Analysis of all
PDAC and CAF cell lines revealed tumor cells as the primary source
of IL-1α (P < .001; Figure 2A). The tumor cell lines showed similar
expression profiles for IL-1α at both gene and protein levels, with the
highest production in PC013 followed by BXPC-3, PC065, and
PC077 (Figures 2D and W2B). High expression levels of IL-1RA
were observed in PDAC cell lines, whereas the CAF cell lines had
no or very low levels of IL-1RA (P < .001; Figure 2B). The IL-1
receptor (IL-1R1) was expressed by all PDAC cell lines tested, al-
though the expression was significantly higher in the CAFs (P <
.001; Figure 2C ). CAFs cocultured in presence of PDAC cell lines
drastically reduced their expression of IL-1R1 (P < .001; Figure 2C ).
Furthermore, the antagonist IL-1RA levels were low to moderate in
BXPC-3 and PC065, whereas PC077 and PC013 secreted high
amounts (Figure 2E ). Of note, none of the PDAC or CAF cell lines
expressed or secreted IL-1β proteins, either in single cultures or in
cocultures (Figure 2F ), even if all of them expressed this cytokine
at the gene level (Figure W2A). Taken together, IL-1α might initiate
a signaling cascade through IL-1R1 resulting in the production of
inflammatory factors necessary for the development and growth of
the PDAC tumor.
Figure 2. Expression of IL-1 agonists, IL-1RA, and IL-1R1 by PDAC and CAF cell lines. Relative IL-1α (A) and IL-1RA (B) gene expression
analyzed by quantitative RT-PCR in PDAC and CAF cell lines cultured alone (S). (C) Relative IL-1R1 gene expression in PDAC and CAF cell
lines from cells cultured alone (S) or cocultured (CC) for 5 days and analyzed by quantitative RT-PCR. IL-1α (D) and IL-1RA (E) protein
secretion profile in PDAC cell lines cultured alone or cocultured with CAF cell lines. IL-1β protein (F) in supernatants from cocultured
PDAC and CAF cell lines. The amount 140 pg/ml of recombinant IL-1β was used as positive control. (A-F) The PC013, BXPC-3, PC065,
and PC077 PDAC and CAF039, CAF055, and CAF073 CAF cell lines were used in these experiments. Data were analyzed using the
Wilcoxon matched-pairs test followed by Mann-Whitney test. *P < .05, **P < .005, and ***P < .001.
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PDAC-Derived IL-1α Is Responsible for the Inflammatory
Profiles Induced in CAF Cell Lines after Coculture
Seeing the diverse expression of IL-1α in PDAC cell lines, with the
highest expression in PC013 and lowest in PC077 (Figures 2D and
W2B), we examined the profile of inflammatory factors induced in
the CAF039 cell line after cross talk with different PDAC cell lines
(PC013, PC065, PC077, and BXPC-3) (Figure 3A). In addition, the
interactions between the high (PC013) and medium (BXPC-3) IL-
1α–expressing cell lines and two additional primary CAF cell lines
(CAF073 and CAF055; Figure W3, A and B) were also assessed to
validate that the inflammatory profile we detected was not unique for
one cell line, that is, CAF039. The cross talk enhanced the expression
of inflammatory factors in CAFs, including IL-1α, IL-6, CCL20,
VEGF-A, CXCL5, and CXCL8. The highest increase in inflammatory
factors was observed in CAF cell lines cocultured together with tumor
cells expressing medium to high levels of IL-1α (Figures 3A and
W3, A and B). For instance, all IL-1α–positive PDAC cell lines caused
up-regulation of the chemoattractant CXCL8 and the cytokine IL-6
(Figure 3A) in CAFs, and the increase correlated to levels of IL-1α
produced by the PDAC cells (Figure 2D). Moreover, the inflamma-
tory profile in CAFs revealed increased expression of ELR-negative
CXC chemokines after coculture with the high IL-1α–expressing cell
line PC013, whereas intermediate IL-1α–expressing cell line BXPC-3
enhanced the levels of CXCL2, CXCL3, CXCL5, and CXCL8 but
not to the same degree (Figures 3A and W3B). We confirmed CXCL8
and IL-6 at protein levels and found the highest levels produced in
cocultures containing PC013 and the lowest in cocultures containing
PC077 (Figure 3, B and C ). To investigate if the up-regulation of in-
flammatory factors was contact dependent, we cocultured PC013 and
CAF039 cells using cell culturing inserts and found up-regulation of
several inflammatory factors in CAFs including CCL20 (P = .004),
IL-6 (P = .036), and CXCL8 (P = .010) (Figure 3D). The involvement
of IL-1α was also confirmed by adding recombinant human IL-1α to
singly cultured CAFs, which resulted in significantly increased levels of
inflammatory factors such as COX-2 (P = .022), IL-6 (P = .036), and
CXCL8 (P = .036) (Figure 3E). Our data suggest that the IL-1α ex-
pression level in PDAC was the determining factor for the level of
inflammatory factors produced by the CAFs underscoring the impor-
tance for the IL-1 signaling cascade in this process.
IL-1α Expression in Tumor Tissue Correlates with Location
and Level of Inflammatory Factor CXCL8 In Vivo
Because the PDAC microenvironment is known to have a high
degree of inflammation, we examined the profile and location of in-
flammatory factors in PDAC tissue samples ex vivo to establish if our
in vitro findings correlated to the actual in vivo situation. An immu-
nohistochemical analysis of the tumor tissue, obtained from patients
PC013, PC065, and PC077, confirmed the expression profile found
in the primary PDAC cell lines with IL-1α (Figures 4A and 2D), and
IL-1RA (Figures 4B and 2E ) localized in the tumor cells, and IL-1R1
(Figures 4C and 2C ), and CXCL8 (Figure 4D) principally expressed
by the fibrotic stroma. Neither tumor cells nor CAFs expressed IL-1β,
but Langerhans islets in a few of the tumor tissues obtain from PDAC
patients stained positive for IL-1β (n = 30) (Figure W4A). Moreover,
all PDAC patients tested (n = 25) negative for IL-1β in plasma (not
shown). The controls, that is, normal pancreatic tissues, were negative
for IL-1α (Figure 4A), IL-1β (Figure W4B), and CXCL8 (Figure 4D),
whereas the cells in the Langerhans islets were positive for both IL-
1RA and IL-1R1 (Figure 4, B and C ) in accordance with previous
findings [22]. We examined the gene expression levels of IL-1α and
CXCL8 in PDAC tissues and compared them to the levels found in
control pancreas tissues. Gene expression levels of IL-1α (P < .001)
and CXCL8 (P < .001) were significantly increased in PDAC tissues
compared with those of controls (Figure 4, E and F ). The gene ex-
pression of CXCL8 showed a positive correlation to the gene expres-
sion levels of IL-1α in PDAC tissue (Figure 4G : P < .001, r2 = 0.46).
Taken together, the ex vivo expression of inflammatory factors in the
PDAC microenvironment corresponded to the findings in our in vitro
PDAC-CAF coculture model with its high expression of inflammatory
factors, especially by the fibrotic stroma, namely, CAFs. Moreover,
these data support IL-1α as an important initiator of inflammatory fac-
tors such as CXCL8.
Exogenous IL-1RA– and IL-1α–Neutralizing Antibodies
Diminished the Inflammatory Environment in PDAC
and CAF Cocultures
To prove that the enhanced inflammatory milieu induced by the
PDAC and CAF cross talk was created by the IL-1α/IL-1R1 signal-
ing pathway, as indicated by our findings, we blocked this pathway
with recombinant human IL-1RA. The inflammatory gene profiles
from the different PDAC cell lines (PC013, BXPC-3, PC065, and
PC077) cocultured with CAF039 cells, established that IL-6 (single [S],
P = .009; cocultured [CC], P < .001), IL-32 (S, P < .001; CC, P =
.011), CXCL1 (S and CC, P < .001), CXCL3 (S, P < .001; CC,
P = .025), CXCL5 (S and CC, P < .001), CXCL6 (S, P < .001;
CC, P = .020), CXCL8 (S and CC, P < .001), and CCL20 (S and
CC, P = .007) were significantly decreased in both single and cocul-
tured CAF039 after IL-1α neutralization. These findings for single
and cocultured CAFs point to both the autocrine and paracrine effects
of IL-1α on CAFs. COX-2 (P = .003), IL-1α (P = .011), IL-1β (P <
.001), and IL-24 (P = .005) were all decreased significantly in the co-
cultured CAFs (Figure 5, A and B) indicating a paracrine up-regulation
of these factors. Of note, the IL-1R1 was significantly increased in
CAFs after neutralization with IL-1RA (Figure 5A), indicating that
the low degree of IL-1α production by the CAFs downregulated this
receptor in an autocrine manner. In addition, we established that the
secretion of IL-6 (S, P = .028; CC, P = .018) and CXCL8 (S, P =
.029; CC, P = .013) was significantly decreased in the CAFs cultured
alone or cocultured with PDAC cell lines after neutralization (Fig-
ure 5C). IL-1RA does not distinguish between IL-1α and IL-1β; hence,
to further investigate the active role of IL-1α in the up-regulation of
inflammatory factors in CAFs, we performed additional experiments
using neutralizing antibodies against IL-1α and IL-1β. Only IL-1α–
neutralizing antibodies decreased the levels of inflammatory factors
compared with those of controls, COX-2 (P = .036), CCL20 (P =
.024), IL-6 (P = .036), and CXCL8 (P = .024), confirming IL-1α
and not IL-1β as the key initiator of inflammatory factors in CAFs
(Figure 5D). These findings showed that tumor cell–derived IL-1α pro-
vokes and maintains the highly inflammatory environment observed
in our in vitro cross talk assays and most likely is the initiator of the
chronic inflammation observed in vivo.
IL-1α Expression Levels in PDAC Tissue Correlated to
Poor Clinical Outcome
When analyzing the relative IL-1α gene expression in PDAC tis-
sues from 30 patients, we found that the patient group expressing the
highest gene levels of IL-1α (>median) (n = 15) had a shorter survival
than the patient group expressing the lowest levels (<median) (n = 15)
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Figure 3. PDAC-derived IL-1α is responsible for the inflammatory profiles induced in CAFs after coculture. (A) PDAC cell lines PC013,
BXPC-3, PC065, and PC077 were cultured alone (S) or cocultured (CC) with the CAF cell line CAF039 (n= 10) for 5 days and assessed for
gene expression levels of inflammatory factors IL-1α, IL-1β, IL-6, CCL20, VEGF-A, COX-2, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and
CXCL8 by quantitative RT-PCR. Protein secretion of IL-6 (B), and CXCL8 (C) from the CAF cell line CAF039 cultured alone or cocultured
for 5 days with the PDAC cell lines PC013, BXPC-3, PC065, and PC077 and (n = 13). (D) The PDAC cell line PC013 was cocultured with
the CAF cell line CAF039 using cell culture transwell inserts for 5 days and analyzed by quantitative RT-PCR. The CAF gene expressions
of CCL20, IL-6, and CXCL8 were analyzed and compared with singly cultured CAFs. (E) CAF039 cells were cultured alone for 5 days in
medium supplemented with 10 pg/ml of recombinant human IL-1α and evaluated for the gene expression of COX-2, IL-6, and CXCL8 by
quantitative RT-PCR. Data were analyzed using the Wilcoxon matched-pairs test followed by Mann-Whitney test, and paired t test was
used for normalized data. *P < .05 and **P < .005.
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(Figure 6A; P = .04). To confirm these findings, IL-1α protein expres-
sion by tumor cells in the PDAC tissue samples was assessed by immu-
nohistochemistry. The negative/low– (n = 12) expressing PDAC tissue
samples showed a better clinical outcome than the moderate/high– (n =
18) expressing patients (Figure 6B; P = .03).
Discussion
Several studies suggest that inflammation functions as a promoter of
tumorigenesis, and identification of the factors contributing to a tumor
supporting microenvironment is of vital importance for prevention
and treatment of cancer. Given that the fibrosis is a large component
in the PDAC tumor mass [4], it is logical to assume that PDAC and
CAF cross talk plays an important role in the production and mainte-
nance of the inflammatory tumor microenvironment. Our study shows
that the chronic inflammation observed in PDAC was mainly pro-
duced by the CAFs and maintained by the IL-1α provided by the
tumor cells. It was clear that the PDAC cells controlled their envi-
ronment through an IL-1α/IL-1R1 cross talk with stromal cells,
that is, in a paracrine manner, thereby promoting the production
of high levels of inflammatory factors from CAFs. Of note, we also
found that the low degree of inflammation seen in single CAFs was
IL-1α dependent in an autocrine manner. It should be noted that
treatment with an IL-1α blocker inhibiting the IL-1 signaling cas-
cade diminished the inflammation and the production of factors
known to be important for supporting tumor growth and spread.
The role of CAFs as a major player in tumor progression is sup-
ported by the fact that many tumors fail to develop unless the stroma
is modified [23], and these changes are induced in a paracrine
Figure 4. PDAC tissues express high levels of inflammatory factors. PDAC and normal pancreas tissue samples were fixed and paraffin
embedded. Tissue sections from PDAC patients PC013, PC065, and PC077 and normal tissues were immunostained with anti–IL-1α,
IL-1RA, IL-1RI, and CXCL8 mAbs followed by secondary mAbs. Images visualize the staining (red) for IL-1α (A), IL-1RA (B), IL-1RI (C) and
CXCL8 (D) Size bar 20 μm. RNA was extracted from PDAC (N = 28) and normal pancreatic tissue samples (N = 10) and assessed for
relative gene expression levels of the inflammatory factors, IL-1α (E) and, CXCL8 (F) by quantitative RT-PCR. IL-1α levels were correlated
to the gene expression of CXCL8 (G). Data were analyzed using the Mann-Whitney test, and correlation was determined using Spearman
nonparametric correlation. *P < .05.
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manner by adjacent tumor cells [14,24]. Several factors have been
shown to be involved in tumor and stroma interactions including
CXCL8, transforming growth factor β, and metalloproteases [25–
27], all observed in our PDAC-CAF cross talk system.
Tumor cells have been shown to express and secrete IL-1, either con-
stitutively or in response to cytokines [28]. One explanation is the poly-
morphisms of the IL-1 gene or IL-1β gene promoter, which have been
shown to be associated with breast and pancreatic adenocarcinomas,
Figure 5. Neutralization of IL-1α signaling with IL-1RA diminishes the inflammation created by the PDAC and CAF cross talk. The CAF cell
line CAF039 was cultured separately (S; left) (A) or together (CC; right) (B) with PDAC cell lines (PC013, BXPC-3, PC065, and PC077) for
5 days with or without IL-1RA and assessed for inflammatory factors (IL-1α, IL-1β, IL-6, CCL20, VEGF-A, COX-2, CXCL1, CXCL2, CXCL3,
CXCL5, CXCL6, and CXCL8) (n = 4) by quantitative RT-PCR. CXCL8 and IL-6 protein secretion (C) measured in supernatants from single
CAF and coculture (CAF039 and PDAC cell lines PC013, PC065, BXPC-3, and PC077) with or without exogenous added IL-1RA. (D) The
PDAC cell line PC013 was cocultured with the CAF cell line CAF039 for 5 days in medium supplemented with 25 μg/ml IL-1α– or IL-1β–
neutralizing antibodies, and the gene expressions of COX-2, IL-6, CCL20 and CXCL8 were analyzed by quantitative RT-PCR and com-
pared with those of controls. Data were analyzed using the Wilcoxon matched-pairs test followed by Mann-Whitney test, and paired
t test was used for normalized data. *P < .05, **P < .005, and ***P < .001.
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respectively [29,30]. Indeed, we found IL-1α protein expressed by
PDAC cells both in vitro and in tumor tissue but detected no expres-
sion of the IL-1β protein. These findings were further confirmed by
treating tumor cell and CAF cocultures with neutralizing antibodies
against IL-1α and IL-1β, showing effects only when blocking IL-1α sig-
naling. This is in contrast to breast cancer cells, which expressed both
IL-1α and IL-1β proteins [31]. These observations indicate that IL-
1α, and not IL-1β, is the activator of the tumor stroma inflammation
in PDAC, and to the best of our knowledge, this has not previously
been shown for PDAC. Mouse tumor models showed that autocrine
production of IL-1β by tumor cells increased their invasive pattern
and potential to metastasize [32,33]. Moreover, induction of IL-1α
expression in PDAC cell lines has been shown to favor their metastatic
and invasive behavior in an orthotopic mouse model consisting of
only PDAC tumor cells [34] and in an in vitromodels [35,36]. A cor-
relation between liver metastasis and expression levels of IL-1α in the
tumor has been found for human gastric and colon cancers
[13,37,38], which reveal how favorable this factor is for the tumor.
Most studies focus on how tumor cells use IL-1 as an autocrine
growth factor [34,39]. Our observations expand these results and
point to an even more important paracrine effect, where the tumor
cells control their environment through an IL-1α/IL-1R1 cross talk
with stromal cells, thereby promoting the production of inflammatory
factors from CAFs.
A prostate cancer study revealed an IL-1–dependent up-regulation
of CXCL1, CXCL2, CXCL3, and CXCL8 in stroma cells [16]. These
findings confirm our results with induction of high levels of CXC che-
mokines in CAFs by high/intermediate IL-1α–expressing PDAC cell
lines and a correlation between IL-1α and CXCL8 mRNA levels in
PDAC tumor tissues. Furthermore, neutralization of IL-1 signaling de-
creased the expression of CXC chemokines in both PDAC cells and
CAFs, which is further evidence for an important role of IL-1α in che-
mokine expression. In breast cancer, the highest expression of CXC
chemokines was found in the metastases, whereas breast cancers with-
out metastatic abilities had low chemokine levels [40]. Our finding of
enhanced expression of angiogenesis associated ELR− chemokines in
CAFs cocultured with high levels of tumor-associated IL-1α, supports
a mechanism where the tumor cells use IL-1α in the generation of a
microenvironment favoring tumor cell migration and angiogenesis. A
factor important in angiogenesis, as tumors outgrow their blood supply
and become hypoxic, is VEGF [41], and the levels of VEGF-A in-
creased after PDAC and CAF cross talk, indicating the supportive role
of cellular interactions have on the tumor growth.
COX-2, CXCL8, CCL20, and IL-6 were increased in CAFs co-
cultured with PDAC cell lines expressing IL-1α. Both CXCL8 and
CCL20 are potent angiogenic factors, and CCL20 has also the ability
to promote the survival and proliferation of cancer cells by increasing
their cell adhesion [42]. This shows clearly that the tumor, that is,
PDAC, directs the fibroblasts to secrete tumor-promoting factors. IL-6
is another tumor-promoting factor that was increased in CAFs after
coculture with PDAC cell lines. IL-6 increases the motility of tumor
cells by diminishing their ability for adherence [43], and many of the
genes targeted by IL-6 are involved in creating an invasive tumor cell
phenotype [44].
COX-2 is normally expressed in association with inflammation,
but it is also an inducible early gene involved in differentiation,
apoptosis, metastasis, angiogenesis, and tumor development [45].
In several types of cancer, including PDAC and breast cancer, the ex-
pression of COX-2 enzyme has been associated with poor prognosis
[46,47]. The levels of this enzyme were enhanced only in cocultures
with PDAC cell lines expressing medium to high levels of IL-1α.
Neutralization of the IL-1α pathway significantly decreased COX-2
expression in the cocultured CAFs. Selective COX-2 inhibitors are
considered for targeted treatment of PDAC in patients [48]. Our find-
ings point to the fact that COX-2 inhibition through blocking of the
IL-1α signaling could have similar effects on the tumor.
Our findings show that treating the tumor and stroma with IL-
1RA– or IL-1α–neutralizing antibodies diminished the inflammation
and production of factors important for supporting tumor growth
and spread. A previous mouse study showed that the use of IL-
1RA treatment decreased metastasis and tumor proliferation in vivo,
as well as decreasing the gene expression and production of VEGF
and CXCL8 [49]. The neutralization of IL-1α using IL-1RA– or
IL-1α–neutralizing antibodies revealed that several inflammatory
Figure 6. IL-1α levels in tumor tissues correlate to patient survival
time. The patients were divided into two groups, comparing the
survival between the PDAC patient group with the lowest (scat-
tered line) (n = 15) and highest (n = 15) PDAC tissue gene expres-
sion levels of IL-1α (± median) analyzed by quantitative RT-PCR
(A). IL-1α protein expression in PDAC tissue samples (n = 30 pa-
tients and each patient in three different experiments) were as-
sessed by immunohistochemistry staining using anti–IL-1α Abs.
The tissue samples were semiquantified using a microscope and
the patients divided into two groups: one group expressing no or
low levels of IL-1α (scattered line) (n = 12) and the other group ex-
pressingmoderate to high levels of IL-1α (n=18) (B). All PDAC tissue
samples were examined in a blinded manner. Log-rank (Mantel-Cox)
test was used for calculation of P values. *P < .05, **P < .005, and
***P < .001.
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factors produced by CAFs are highly dependent of the IL-1 pathway
for their expression. Moreover, we confirmed and even expanded the
IL-1 tumor-associated gene fingerprint in CAFs suggested by Erez
et al. [50] to include IL-24, IL-32, and CCL20 and the ELR− CXC
chemokines CXCL3, CXCL5, CXCL6, and CXCL8.
In summary, we found that the cross talk between PDAC and its
stroma cells, namely, CAFs, contributes to the generation of the in-
flammatory environment through the IL-1α signaling cascade. The
microenvironment created by IL-1α was beneficial for tumor survival
because it contains factors associated with, for example, angiogenesis,
and tumor cell migration and IL-1α levels correlated to the severity
of the disease. Neutralization of IL-1α decreased the inflammation,
and thus, targeting this pathway could be a new strategy of treating
PDAC seeing that its expression has a negative effect on the patients’
survival. Of note, new candidates for blocking IL-1, namely, cyto-
kine traps specific for IL-1α, could facilitate this considerably.
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Figure W1. Characterization of primary PDAC and CAF cell lines propagated from tumor tissues. (A) Visualization of PC013 and CAF039
cell lines cocultured together in vitro for 5 days. Pancreatic tumor tissue from a PDAC patient and normal tissue stained with Ki-67. Size
bars, 50 and 30 μm. (B) RNA extracted from the CAF cell lines CAF039, CAF055, and CAF073 and the primary PDAC cell line PC013 were
assessed for α-SMA and vimentin expression by PCR followed by gel electrophoresis to visualize the gene products. (C) Singly cultured
PDAC cell line, (D) CAFs, and (E) cocultured PDAC and CAFs all assessed for anti-CD326 APC-labeled MAb and analyzed by flow cytom-
etry. (E) PDAC cells were sorted from the R1 gate and CAFs were sorted from the R2 gate. (F) Gene array heat map from a representative
experiment showing single and cocultured PC013 and CAF039 cells. The cocultured cells were labeled with CD326 and sorted into pure
cell populations, and data were analyzed by d-Chip software.
Figure W2. Gene expression of IL-1α and IL-1β in PDAC and CAF
cell lines. (A) IL-1β gene expression in cocultured (CC) PDAC and
CAF cell lines normalized to respective cell lines cultured alone (S).
(B) Relative IL-1α gene expression profile in PDAC cell lines cul-
tured alone or cocultured with CAFs. The PDAC cell lines PC013,
BXPC-3, PC065, and PC077 and the CAF cell lines CAF039,
CAF055, and CAF073 were cultured alone or cocultured together
for 5 days. *P < .05, **P < .005, and ***P < .001.
Figure W3. The CAF coculture gene profile is universal when cultured with IL-1α expressing cell lines. RNA was prepared from PDAC
cell lines PC013 (IL-1α high) and BXPC-3 (IL-1α medium) and CAF cell lines CAF055 and CAF073 after they had been cultured alone or
cocultured (PC013/CAF073 [A] and BXPC-3/CAF055 [B], respectively) for 5 days and assessed for expression levels of inflammatory
factors (n = 2). The gene expression in cocultured (CC) CAFs was normalized to CAFs cultured alone (S).
Figure W4. IL-1β expression in PDAC and normal pancreatic tissue. PDAC and normal pancreatic tissue samples were fixed and paraffin
embedded. The tissue sections from (A) PDAC patients (n = 30) and normal pancreatic tissues (n = 10) (B) were immunostained with
anti–IL-1β, followed by secondary antibodies. The PDAC photograph visualizes the staining (red) for IL-1β in a Langerhans islet. Size
bars, 30 μm.
